🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

$AMGN EVP R&D Jay Bradner disclosed on Amgen’s Q4 earnings call that the mid-year disclosure of detailed Phase II MariTide data in obesity will be at the ADA meeting in June.

Urinary disease biotech Jyong Biotech sets terms for $19 million US IPO $MENS $IPO #IPO buff.ly/3ECfYgC

Metabolic disease biotech Aardvark Therapeutics sets terms for $100 million IPO $AARD $IPO #IPO buff.ly/4jJZinF

Cystic fibrosis biotech Sionna Therapeutics prices upsized IPO at $18, the high end of the range $SION $IPO #IPO buff.ly/3COWhSg

Metabolic disease biotech Aardvark Therapeutics prices IPO at $16, the low end of the range $AARD $IPO #IPO buff.ly/3QdZVbH

$SUPN Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression Fail globenewswire.com/news-release/2…

$CTMX $AMGN are abandoning development of their EGFR-CD3 probody TCE "based on clinical observations to-date" $JANX $VIR

Today, FDA made recommendations to vaccine manufacturers for the strains to be used in flu vaccines for the 2025-2026 U.S. flu season following a thorough and comprehensive review of U.S. and global surveillance data. fda.gov/vaccines-blood…

With today’s action, we anticipate there will not be any impact on timing or availability of vaccines for the American public.

SCOOP: New FDA commissioner Martin Makary was sworn in Friday before HHS tried to push Peter Marks out, knew it was going to happen and did not stop it. insights.citeline.com/pink-sheet/geo…

Why it matters: The events may concern FDA stakeholders who were hoping Makary would be a check on the Trump Administration's attempts to intervene at the FDA and advance policies that do not align with the best scientific evidence.

Dear PR people pushing routine health-related stories: PLEASE READ THE ROOM!

The exemption is a relief to industry, which is trying to stay focused on business as usual despite chaotic disruptions at US health agencies. But the situation remains fluid and some caution the policy could change. insights.citeline.com//scrip/busines…

Pharma Exhales, Dodging A Financial Blow With Tariff Exemption ow.ly/gkGj1064thC #PharmaScrip

$SGMO Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System $18m upfront businesswire.com/news/home/2025…

We only had one small Lego set jump off a shelf in my 10yo son’s room and our dog was upset for a while. I think I felt a small aftershock, but it might’ve been other outdoor noise? But while this was the biggest earthquake I can remember in San Diego for a while, it wasn’t bad.

The 2025 Scrip Awards Is Open For Entries ow.ly/UeZT10668gF #PharmaScrip

$XNCR Xencor Announces Positive Interim Results From First-in-Human Healthy Volunteer Study of XmAb942, a High-Potency Extended Half-Life Anti-TL1A Antibody, in Development for Treatment of Inflammatory Bowel Disease businesswire.com/news/home/2025…

$CYTK Down about 14% after hours

Autoimmune biotech Odyssey Therapeutics withdraws $100 million IPO $ODTX $IPO #IPO zpr.io/zNWpLC3tTUVr